Basket | Login


Trials@Home consortium invites patients and patient organisations to complete a survey on Remote Decentralised Clinical Trials

Wednesday 20 January 2021

The Trials@Home consortium, a public-private-partnership funded by the European Commission and The European Federation of Pharmaceutical Industries and Associations (EFPIA), will explore the opportunities of moving clinical trials from the traditional clinic setting to the participant’s immediate surroundings. These so-called Remote Decentralised Clinical Trials (RDCTs) make use of new digital innovations and enable participants to visit a clinical trial centre less frequently, if at all.

In order to create these outcomes and develop training and educational materials, the consortium has launched a survey, aimed at patient organisations and the patients they represent, to explore opinions on RDCTs and find out how to help people to understand the matter better, by developing tailored training and education materials.

At the end of the survey, respondents are given the option to leave their contact details, if they wish to be kept informed about the outcomes of the survey, the resulting training materials or the possibility to potentially join panel discussions in the future.  You can take the survey, here: